Valuation: FDC Limited

Market Cap 52.29B 543M 477M 444M 407M 765M 777M 5.27B 2.06B 25.71B 2.04B 1.99B 88.89B P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 47.15B 490M 430M 400M 367M 689M 700M 4.75B 1.86B 23.18B 1.84B 1.8B 80.14B EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day+2.40%
1 week-2.00%
Current month-2.86%
1 month+0.16%
3 months+12.24%
6 months+11.45%
Current year-2.83%
1 week 397.55
Extreme 397.55
424.95
1 month 397.55
Extreme 397.55
442
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
528.3
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 48 01/01/2002
Director/Board Member 63 30/09/1993
Chairman 90 16/11/2009
Change 5-day change 1-year change 3-year change Capi.($)
+2.40%-2.00%-16.09%+20.49% 695M
+0.86%+1.43%+48.50%+160.39% 1,067B
+1.59%+4.09%+55.34%+53.96% 635B
+0.95%+1.91%+35.91%+81.14% 458B
+1.60%+6.25%+33.95%+29.84% 347B
-0.60%+1.52%+35.68%+39.76% 295B
-0.14%+0.60%+16.17%+17.53% 262B
+0.09%-2.82%-28.29%-41.71% 216B
+1.22%+2.66%+21.87%+59.73% 203B
-1.18%-3.70%+14.23%+66.51% 161B
Average +0.57%+0.99%+21.73%+48.76% 364.37B
Weighted average by Cap. +0.55%+1.95%+35.80%+77.66%

Financials

2024 2025
Net sales 19.43B 202M 177M 165M 151M 284M 289M 1.96B 765M 9.55B 757M 741M 33.03B 21.08B 219M 192M 179M 164M 308M 313M 2.12B 830M 10.36B 822M 804M 35.83B
Net income 3.05B 31.69M 27.84M 25.89M 23.76M 44.64M 45.32M 307M 120M 1.5B 119M 116M 5.19B 2.67B 27.7M 24.33M 22.63M 20.76M 39.01M 39.62M 269M 105M 1.31B 104M 102M 4.53B
Net Debt -4.55B -47.24M -41.49M -38.59M -35.41M -66.53M -67.55M -458M -179M -2.24B -177M -174M -7.73B -5.15B -53.47M -46.97M -43.68M -40.08M -75.31M -76.47M -519M -203M -2.53B -201M -196M -8.75B
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
24/07/26 INR 411.30 +2.40% 3,751
23/07/26 INR 401.65 -1.99% 4,247
22/07/26 INR 409.80 -0.94% 11,412
21/07/26 INR 413.70 -1.14% 3,448
20/07/26 INR 418.45 -0.30% 2,745
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B